SFZYD has also been shown to effectively treat dysmenorrhea, a primary symptom of blood stasis, by regulating the expression of inflammatory cytokines, such as IL-1β, TNF-α, IL-10, IL-2 and IL-12, in a rat model [19]. Here, IL2 is linked to Dysmenorrhea.